Association study of monoamine oxidase and catechol-O-methyltransferase genes with smoking behavior

Pharmacogenetics and Genomics

Volumn 17, Issue 10, 2007, Pages 867-872

  Tochigi, Mamoru ^a   Suzuki, Kentaro ^a   Kato, Chieko ^a   Otowa, Takeshi ^a   Hibino, Hiroyuki ^a   Umekage, Tadashi ^a,b   Kato, Nobumasa ^a   Sasaki, Tsukasa ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Gene gene interaction; Nicotine; The Revised NEO Personality Inventory; The State Trait Anxiety Inventory; Tobacco

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CATECHOL METHYLTRANSFERASE; DOPAMINE; METHIONINE; NICOTINE; VALINE;

ADULT; ARTICLE; BIOLOGICAL TRAIT; CATALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DNA POLYMORPHISM; FEMALE; GENE FUNCTION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; INTRON; JAPANESE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; SMOKING HABIT; STRUCTURED INTERVIEW; TANDEM REPEAT;

ADULT; CATECHOL O-METHYLTRANSFERASE; EPISTASIS, GENETIC; FEMALE; GENOTYPE; HUMANS; INTRONS; JAPAN; MALE; MONOAMINE OXIDASE; POLYMORPHISM, GENETIC; SMOKING;

NICOTIANA TABACUM;

EID: 34648837874     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3282e9a51e     Document Type: Article

References (22)

1. Sullivan PF, Kendler KS. The genetic epidemiology of smoking. Nicotine Tob Res 1999; 1:S51-S57.
2. Pontieri FE, Tanda G, Orzi F, DiChiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996; 382:255-257.
3. Sabol S, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998; 103:273-279.
4. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 1999; 8:621-624.
5. Wiesbeck GA, Wodarz N, Weijers HG, Dursteler-MacFarland KM, Wurst FM, Walter M, et al. A functional polymorphism in the promoter region of the monoamine oxidase A gene is associated with the cigarette smoking quantity in alcohol-dependent heavy smokers. Neuropsychobiology 2006; 53:181-185.
6. Jin Y, Chen D, Hu Y, Guo S, Sun H, Lu A, et al. Association between monoamine oxidase gene polymorphisms and smoking behaviour in Chinese males. Int J Neuropsychopharmacol 2006; 9:557-564.
7. McKinney EF, Walton RT, Yudkin P, Fuller A, Haldar NA, Mant D, et al. Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. Pharmacogenetics 2000; 10:483-491.
8. Huang S, Cook DG, Hinks LJ, Chen XH, Ye S, Gilg JA, et al. CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents. Pharmacogenet Genomics 2005; 15:839-850.
9. Costa P, Checkoway H, Levy D, Smith-Weller T, Franklin GM, Swanson PD, et al. Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease. Am J Med Genet 1997; 74:154-156.
10. Balciuniene J, Emilsson L, Oreland L, Pettersson U, Jazin EE. Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Hum Genet 2002; 110:1-7.
11. Ito H, Hamajima N, Matsuo K, Okuma K, Sato S, Ueda R, et al. Monoamine oxidase polymorphisms and smoking behaviour in Japanese. Pharmacogenetics 2003; 13:73-79.
12. Costa-Mallen P, Costa LG, Checkoway H. Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men. Neurosci Lett 2005; 385:158-162.
13. Pivac N, Knezevic J, Mustapic M, Dezeljin M, Muck-Seler D, Kozaric-Kovacic D, et al. The lack of association between monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity among men. Life Sci 2006; 79:45-49.
14. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995; 34:4202-4210.
15. Colilla S, Lerman C, Shields PG, Jepson C, Rukstalis M, Berlin J, et al. Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenet Genomics 2005; 15:393-398.
16. Beuten J, Payne TJ, Ma JZ, Li MD. Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations. Neuropsychopharmacology 2006; 31:675-684.
17. Enoch MA, Waheed JF, Harris CR, Albaugh B, Goldman D. Sex differences in the influence of COMT Val158Met on alcoholism and smoking in plains American Indians. Alcohol Clin Exp Res 2006; 30:399-406.
18. David SP, Johnstone E, Griffiths SE, Murphy M, Yudkin P, Mant D, et al. No association between functional catechol O-methyltransferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation. Pharmacogenetics 2002; 12:265-268.
19. Guo S, Chen DF, Zhou DF, Sun HQ, Wu GY, Haile CN, et al. Association of functional catechol O-methyltransferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers. Psychopharmacology 2007; 190:449-456.
20. Tochigi M, Otowa T, Hibino H, Kato C, Otani T, Umekage T, et al. Combined analysis of association between personality traits and three functional polymorphisms in the tyrosine hydroxylase, monoamine oxidase A, and catechol-O-methyltransferase genes. Neurosci Res 2006; 54:180-185.
21. Costa PT, McCrae RL. Revised NEO personality inventory and NEO five-factor inventory: professional manual. Odessa, FL: Psychological Assessment Resources; 1992.
22. Spielberger CD, Gorsuch RL, Lushene RE. STAI manual. Palo Alto, California, USA: Consulting Psychologist Press; 1970; 23-49.